The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Companion Animal Pharmaceutical Market Research Report 2024

Global Companion Animal Pharmaceutical Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1721860

No of Pages : 85

Synopsis
Companion animals (dogs, cats, and horses) have come to play an important part in the lives of many people. They provide companionship and a sense of responsibility, demand care and attention, and respond with affection.
The global Companion Animal Pharmaceutical market was valued at US$ 1125 million in 2023 and is anticipated to reach US$ 1988.5 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 24%.
This report aims to provide a comprehensive presentation of the global market for Companion Animal Pharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Animal Pharmaceutical.
Report Scope
The Companion Animal Pharmaceutical market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Companion Animal Pharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Companion Animal Pharmaceutical companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Bayer Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Parnell
Segment by Type
Infectious Diseases
Dermatologic Diseases
Pain
Orthopedic Diseases
Behavioral Diseases
Other Indications
Segment by Application
Dogs
Cats
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Companion Animal Pharmaceutical companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Animal Pharmaceutical Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Infectious Diseases
1.2.3 Dermatologic Diseases
1.2.4 Pain
1.2.5 Orthopedic Diseases
1.2.6 Behavioral Diseases
1.2.7 Other Indications
1.3 Market by Application
1.3.1 Global Companion Animal Pharmaceutical Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Dogs
1.3.3 Cats
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Companion Animal Pharmaceutical Market Perspective (2019-2030)
2.2 Companion Animal Pharmaceutical Growth Trends by Region
2.2.1 Global Companion Animal Pharmaceutical Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Companion Animal Pharmaceutical Historic Market Size by Region (2019-2024)
2.2.3 Companion Animal Pharmaceutical Forecasted Market Size by Region (2025-2030)
2.3 Companion Animal Pharmaceutical Market Dynamics
2.3.1 Companion Animal Pharmaceutical Industry Trends
2.3.2 Companion Animal Pharmaceutical Market Drivers
2.3.3 Companion Animal Pharmaceutical Market Challenges
2.3.4 Companion Animal Pharmaceutical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Animal Pharmaceutical Players by Revenue
3.1.1 Global Top Companion Animal Pharmaceutical Players by Revenue (2019-2024)
3.1.2 Global Companion Animal Pharmaceutical Revenue Market Share by Players (2019-2024)
3.2 Global Companion Animal Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Animal Pharmaceutical Revenue
3.4 Global Companion Animal Pharmaceutical Market Concentration Ratio
3.4.1 Global Companion Animal Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Animal Pharmaceutical Revenue in 2023
3.5 Companion Animal Pharmaceutical Key Players Head office and Area Served
3.6 Key Players Companion Animal Pharmaceutical Product Solution and Service
3.7 Date of Enter into Companion Animal Pharmaceutical Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Animal Pharmaceutical Breakdown Data by Type
4.1 Global Companion Animal Pharmaceutical Historic Market Size by Type (2019-2024)
4.2 Global Companion Animal Pharmaceutical Forecasted Market Size by Type (2025-2030)
5 Companion Animal Pharmaceutical Breakdown Data by Application
5.1 Global Companion Animal Pharmaceutical Historic Market Size by Application (2019-2024)
5.2 Global Companion Animal Pharmaceutical Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Companion Animal Pharmaceutical Market Size (2019-2030)
6.2 North America Companion Animal Pharmaceutical Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Companion Animal Pharmaceutical Market Size by Country (2019-2024)
6.4 North America Companion Animal Pharmaceutical Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Companion Animal Pharmaceutical Market Size (2019-2030)
7.2 Europe Companion Animal Pharmaceutical Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Companion Animal Pharmaceutical Market Size by Country (2019-2024)
7.4 Europe Companion Animal Pharmaceutical Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Animal Pharmaceutical Market Size (2019-2030)
8.2 Asia-Pacific Companion Animal Pharmaceutical Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Companion Animal Pharmaceutical Market Size by Region (2019-2024)
8.4 Asia-Pacific Companion Animal Pharmaceutical Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Companion Animal Pharmaceutical Market Size (2019-2030)
9.2 Latin America Companion Animal Pharmaceutical Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Companion Animal Pharmaceutical Market Size by Country (2019-2024)
9.4 Latin America Companion Animal Pharmaceutical Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Animal Pharmaceutical Market Size (2019-2030)
10.2 Middle East & Africa Companion Animal Pharmaceutical Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2019-2024)
10.4 Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Detail
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Companion Animal Pharmaceutical Introduction
11.1.4 Zoetis Revenue in Companion Animal Pharmaceutical Business (2019-2024)
11.1.5 Zoetis Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Companion Animal Pharmaceutical Introduction
11.2.4 Boehringer Ingelheim Revenue in Companion Animal Pharmaceutical Business (2019-2024)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Merck Animal Health
11.3.1 Merck Animal Health Company Detail
11.3.2 Merck Animal Health Business Overview
11.3.3 Merck Animal Health Companion Animal Pharmaceutical Introduction
11.3.4 Merck Animal Health Revenue in Companion Animal Pharmaceutical Business (2019-2024)
11.3.5 Merck Animal Health Recent Development
11.4 Elanco Animal Health
11.4.1 Elanco Animal Health Company Detail
11.4.2 Elanco Animal Health Business Overview
11.4.3 Elanco Animal Health Companion Animal Pharmaceutical Introduction
11.4.4 Elanco Animal Health Revenue in Companion Animal Pharmaceutical Business (2019-2024)
11.4.5 Elanco Animal Health Recent Development
11.5 Bayer Animal Health
11.5.1 Bayer Animal Health Company Detail
11.5.2 Bayer Animal Health Business Overview
11.5.3 Bayer Animal Health Companion Animal Pharmaceutical Introduction
11.5.4 Bayer Animal Health Revenue in Companion Animal Pharmaceutical Business (2019-2024)
11.5.5 Bayer Animal Health Recent Development
11.6 Virbac
11.6.1 Virbac Company Detail
11.6.2 Virbac Business Overview
11.6.3 Virbac Companion Animal Pharmaceutical Introduction
11.6.4 Virbac Revenue in Companion Animal Pharmaceutical Business (2019-2024)
11.6.5 Virbac Recent Development
11.7 Dechra Veterinary Products
11.7.1 Dechra Veterinary Products Company Detail
11.7.2 Dechra Veterinary Products Business Overview
11.7.3 Dechra Veterinary Products Companion Animal Pharmaceutical Introduction
11.7.4 Dechra Veterinary Products Revenue in Companion Animal Pharmaceutical Business (2019-2024)
11.7.5 Dechra Veterinary Products Recent Development
11.8 Ceva
11.8.1 Ceva Company Detail
11.8.2 Ceva Business Overview
11.8.3 Ceva Companion Animal Pharmaceutical Introduction
11.8.4 Ceva Revenue in Companion Animal Pharmaceutical Business (2019-2024)
11.8.5 Ceva Recent Development
11.9 Vetoquinol
11.9.1 Vetoquinol Company Detail
11.9.2 Vetoquinol Business Overview
11.9.3 Vetoquinol Companion Animal Pharmaceutical Introduction
11.9.4 Vetoquinol Revenue in Companion Animal Pharmaceutical Business (2019-2024)
11.9.5 Vetoquinol Recent Development
11.10 Meiji
11.10.1 Meiji Company Detail
11.10.2 Meiji Business Overview
11.10.3 Meiji Companion Animal Pharmaceutical Introduction
11.10.4 Meiji Revenue in Companion Animal Pharmaceutical Business (2019-2024)
11.10.5 Meiji Recent Development
11.11 Ouro Fino Saude
11.11.1 Ouro Fino Saude Company Detail
11.11.2 Ouro Fino Saude Business Overview
11.11.3 Ouro Fino Saude Companion Animal Pharmaceutical Introduction
11.11.4 Ouro Fino Saude Revenue in Companion Animal Pharmaceutical Business (2019-2024)
11.11.5 Ouro Fino Saude Recent Development
11.12 Parnell
11.12.1 Parnell Company Detail
11.12.2 Parnell Business Overview
11.12.3 Parnell Companion Animal Pharmaceutical Introduction
11.12.4 Parnell Revenue in Companion Animal Pharmaceutical Business (2019-2024)
11.12.5 Parnell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’